Literature DB >> 17276680

Quinuclidines as selective agonists for alpha-7 nicotinic acetylcholine receptors.

Fedra M Leonik1, Roger L Papke, Nicole A Horenstein.   

Abstract

The alpha7 subtype of the neuronal nicotinic acetylcholine receptors (nAChRs) was targeted for the design of selective agonists deriving from the quinuclidine scaffold. Arylidene groups at the 3-position and N-methyl quinuclidine were found to be selective agonists with EC(50)s of 1.5 and 40 microM, respectively.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17276680     DOI: 10.1016/j.bmcl.2007.01.003

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  4 in total

Review 1.  High throughput electrophysiology with Xenopus oocytes.

Authors:  Roger L Papke; Cathy Smith-Maxwell
Journal:  Comb Chem High Throughput Screen       Date:  2009-01       Impact factor: 1.339

2.  Multiple pharmacophores for the selective activation of nicotinic alpha7-type acetylcholine receptors.

Authors:  Nicole A Horenstein; Fedra M Leonik; Roger L Papke
Journal:  Mol Pharmacol       Date:  2008-09-02       Impact factor: 4.436

3.  Synthesis of H-bonding probes of alpha7 nAChR agonist selectivity.

Authors:  Jingyi Wang; Roger L Papke; Nicole A Horenstein
Journal:  Bioorg Med Chem Lett       Date:  2008-11-18       Impact factor: 2.823

Review 4.  Alpha7 nicotinic acetylcholine receptor: a link between inflammation and neurodegeneration.

Authors:  Concepcion Conejero-Goldberg; Peter Davies; Luis Ulloa
Journal:  Neurosci Biobehav Rev       Date:  2007-11-28       Impact factor: 8.989

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.